focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCroda International Regulatory News (CRDA)

Share Price Information for Croda International (CRDA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,751.00
Bid: 4,775.00
Ask: 4,779.00
Change: -132.00 (-2.70%)
Spread: 4.00 (0.084%)
Open: 4,886.00
High: 4,897.00
Low: 4,748.00
Prev. Close: 4,883.00
CRDA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Restatement of results for new reporting structure

4 Jun 2021 13:13

RNS Number : 9165A
Croda International PLC
04 June 2021
 

Regulatory News Announcement

4 June 2021

 

Croda International Plc

Restatement of results for new reporting structure

 

Croda International Plc ('Croda' or 'the Group') announced in November 2020 that from 2021 it would amend its reporting structure to report under four sectors - Consumer Care, Life Sciences, Performance Technologies and Industrial Chemicals.

 

In advance of its half year results on 27 July 2021, the Group is publishing restated segmental results for half year 2020 to provide a like-for-like comparator.

 

Consumer Care comprises the Personal Care sector, including Iberchem, a customer previously reported within Life Sciences, and the Home Care business unit from Performance Technologies.

 

The table below sets out the new structure, showing half year 2020 results as previously reported and the results for the same period restated to reflect the new structure. There is no impact from the Group's acquisitions of Avanti and Iberchem as they were both completed in the second half of 2020.

Sales

Adjusted operating profit*

Half year ended 30 June 2020

Reported currency

 

As

reported

£m

Restated

£m

As

reported

£m

Restated

£m

Consumer Care

226.7

251.1

68.9

73.7

Life Sciences

182.9

179.8

59.4

57.8

Performance Technologies

216.3

195.0

32.7

29.5

Industrial Chemicals

47.0

47.0

0.6

0.6

Group

672.9

672.9

161.6

161.6

 

* Adjusted operating profit is stated before exceptional items, acquisition costs and amortisation of intangible assets arising on acquisition.

 

Further information

 

David Bishop, Director of Investor Relations and Corporate Affairs: +44 7823 874428

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEAAKLEENFEFA
Date   Source Headline
27th Jul 20165:28 pmRNSHolding(s) in Company
26th Jul 20167:00 amRNSResults for the six months ended 30 June 2016
13th Jul 20163:22 pmRNSDirector/PDMR Shareholding
12th Jul 20165:35 pmRNSHolding(s) in Company
11th Jul 20162:23 pmRNSHolding(s) in Company
8th Jul 201610:50 amRNSHolding(s) in Company
13th Jun 20168:00 amRNSDirector/PDMR Shareholding
7th Jun 201612:25 pmRNSDirector/PDMR Shareholding
31st May 20169:54 amRNSHolding(s) in Company
11th May 20163:49 pmRNSDirector/PDMR Shareholding
3rd May 20165:16 pmRNSHolding(s) in Company
29th Apr 201612:22 pmRNSDirector/PDMR Shareholding
28th Apr 20164:00 pmRNSTransaction in Own Shares
28th Apr 201612:09 pmRNSHolding(s) in Company
28th Apr 201612:06 pmRNSResult of AGM
27th Apr 20167:00 amRNSTrading update for the first quarter of 2016
25th Apr 201610:57 amRNSDirector/PDMR Shareholding
12th Apr 20162:46 pmRNSDirector/PDMR Shareholding
4th Apr 20165:41 pmRNSHolding(s) in Company
31st Mar 20164:52 pmRNSHolding(s) in Company
21st Mar 20165:45 pmRNSAnnual Financial Report
21st Mar 20163:20 pmRNSDirector/PDMR Shareholding
21st Mar 20163:19 pmRNSHolding(s) in Company
17th Mar 20167:00 amRNSCapital Markets Event
14th Mar 201612:07 pmRNSHolding(s) in Company
11th Mar 20164:12 pmRNSDirector/PDMR Shareholding
10th Mar 20169:59 amRNSDirector/PDMR Shareholding
7th Mar 20162:51 pmRNSDirector/PDMR Shareholding
3rd Mar 20164:52 pmRNSHolding(s) in Company
29th Feb 20165:03 pmRNSHolding(s) in Company
23rd Feb 20167:00 amRNSFinal Results
11th Feb 20164:56 pmRNSHolding(s) in Company
11th Feb 20162:26 pmRNSDirector/PDMR Shareholding
9th Feb 20169:02 amRNSHolding(s) in Company
8th Feb 20169:55 amRNSHolding(s) in Company
4th Feb 20163:58 pmRNSHolding(s) in Company
18th Jan 20165:25 pmRNSHolding(s) in Company
18th Jan 20169:36 amRNSHolding(s) in Company
13th Jan 20164:47 pmRNSHolding(s) in Company
12th Jan 20162:40 pmRNSDirector/PDMR Shareholding
11th Jan 20164:28 pmRNSHolding(s) in Company
11th Dec 20152:32 pmRNSDirector/PDMR Shareholding
3rd Dec 201510:00 amRNSDirector/PDMR Shareholding
1st Dec 20157:00 amRNSAcquisition
25th Nov 20155:16 pmRNSHolding(s) in Company
23rd Nov 20151:56 pmRNSDirector/PDMR Shareholding
11th Nov 20152:44 pmRNSDirector/PDMR Shareholding
5th Nov 20157:00 amRNSTrading Update for the third quarter of 2015
3rd Nov 201510:42 amRNSDirector/PDMR Shareholding
13th Oct 20153:56 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.